Moffitt Genetics Corp

Aster Insights, formerly known as M2GEN, is a pioneering organization in oncology, dedicated to accelerating the discovery and development of cancer treatments through innovative scientific and clinical intelligence. With a foundation of nearly half a million patients, the company partners with drug, biologics, diagnostics, and medical device developers to transform the landscape of cancer research and care.

Since its inception in 2006, Aster Insights has made significant strides, including the establishment of the Oncology Research Information Exchange Network (ORIEN) and the Total Cancer Care (TCC) initiative, which has accrued over 4 million patients. The company has also achieved notable milestones, such as exceeding 150 research collaborations and over 100 publications, solidifying its role as a leader in patient-focused cancer research.

Generated from the website